Valvular heart disease and pregnancy - Part II: Prosthetic valves

被引：179

作者：

Elkayam, U ^{[1
]}

Bitar, F ^{[1
]}

机构：

[1] Univ So Calif, Keck Sch Med, Med Ctr, Heart Failure Program, Los Angeles, CA 90033 USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2005年 / 46卷 / 03期

关键词：

D O I：

10.1016/j.jacc.2005.02.087

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A large number of prosthetic heart valves (PHV) are being implanted in patients with both congenital and acquired valvular disease. Many of the recipients of such valves are women of childbearing age who desire to have children. The main issues involved with pregnancy in a patient with PHV include the selection of PHV in women during their childbearing age, risks to both the mother and the fetus associated with pregnancy and the management of the patients with PHV during gestation.

引用

页码：403 / 410

页数：8

共 84 条

[1] The Ross procedure is the procedure of choice for congenital aortic valve disease [J].

Al-Halees, Z ;

Pieters, F ;

Qadoura, F ;

Shahid, M ;

Al-Amri, M ;

Al-Fadley, F .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2002, 123 (03) :437-442

[2]

Anbarasan C, 2001, J HEART VALVE DIS, V10, P393

[3]

[Anonymous], 2002, CLIN CARD CONS REP, V3, P1

[4]

[Anonymous], 2004, LOV INJ PACK INS

[5]

[Anonymous], 2002, LOV INJ PACK INS

[6]

Arnaout M. Samir, 1998, Clinical and Experimental Obstetrics and Gynecology, V25, P101

[7]

Avila WS, 2002, J HEART VALVE DIS, V11, P864

[8]

BADDUKE BR, 1991, J THORAC CARDIOV SUR, V102, P179

[9] A prospective triat that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levets of anticoagulation [J].

Barbour, LA ;

Oja, JL ;

Schultz, LK .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (03) :1024-1029

[10] Use of antithrombotic agents during pregnancy [J].

Bates, SA ;

Greer, IA ;

Hirsh, J ;

Ginsberg, JS .

CHEST, 2004, 126 (03) :627S-644S

← 1 2 3 4 5 6 7 8 9 →